Dose-response effect of Red Maca (Lepidium meyenii) on benign prostatic hyperplasia induced by testosterone enanthate

Phytomedicine

Volumn 14, Issue 7-8, 2007, Pages 460-464

  Gasco, M ^a   Villegas, L ^a   Yucra, S ^a   Rubio, J ^a   Gonzales, G F ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

benign prostatic hyperplasia; glucosinolates; Lepidium meyenii (Red Maca); rats

Indexed keywords

BENZYL GLUCOSINOLATE; FINASTERIDE; GLUCOSINOLATE; LEPIDIUM MEYENII EXTRACT; OXIDOREDUCTASE; TESTOSTERONE; TESTOSTERONE ENANTATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE WEIGHT; RAT; RED MACA; SEMINAL VESICLE WEIGHT; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LEPIDIUM; MALE; ORGAN SIZE; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; RATS; RATS, SPRAGUE-DAWLEY; SEMINAL VESICLES; TESTOSTERONE;

ANIMALIA; LEPIDIUM MEYENII; RATTUS;

EID: 34447563971     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.12.003     Document Type: Article

References (18)

1. Bogani P., Simonini F., Iriti M., Rossoni M., Faoro F., Poletti A., and Visioli F. Lepidium meyenii (Maca) does not exert direct androgenic activities. J. Ethnopharmacol. 104 (2006) 415-417
2. Chiao J.W., Wu H., Ramaswamy G., Conaway C.C., Chung F.L., Wang L., and Liu D. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 25 (2004) 1403-1408
3. Fahey J.W., Zalcman A.T., and Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 56 (2001) 5-51
4. Gao W., Kerabey J.D., Nair V.A., Chung K., Parlow A.F., Miller D.D., and Dalton J.T. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5 alpha-reductase inhibitor Finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia. Endocrinology 145 (2004) 5420-5428
5. Gonzales G.F., Miranda S., Nieto J., Fernandez G., Yucra S., Rubio J., Yi P., and Gasco M. Red Maca (Lepidium meyenii) reduced prostate size in rats. Reproductive Biol. Endocrinol. 3 (2005) 5
6. Kashiwagi B., Shibata Y., Ono Y., Suzuki R., Honma S., and Suzuki K. Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: establishment of a new highly sensitive simultaneous androgen measurement method. J. Androl. 26 (2005) 586-591
7. Kristal A.R., and Lampe J.W. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr. Cancer 42 (2002) 1-9
8. Le H.T., Schaldach C.M., Firestone G.L., and Bjeldanes L.F. Plant derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J. Biol. Chem. 278 (2003) 21136-21145
9. Ma Z., Hung Nguyen T., Hoa Huynh T., Tien Do P., and Huynh H. Reduction of rat prostate weight by combined quercetin-Finasteride treatment is associated with cell cycle deregulation. J. Endocrinol. 181 (2004) 493-507
10. Martinez Caballero S., Carricajo Fernandez C., and Perez Fernandez R. Effect of an integral suspension of Lepidium latifolium on prostate hyperplasia in rats. Fitoterapia 75 (2004) 187-191
11. Nachshon-Kedmi M., Yannai S., Haj A., and Fares F.A. Indole-3-carbinol and 3′3-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem. Toxicol. 41 (2003) 745-752
12. Nachshon-Kedmi M., Yannai S., and Fares F.A. Induction of apoptosis in human prostate cancer cell line, PC3, by 3′3′-diindolylmethane through the mitochondrial pathway. Br. J. Cancer 91 (2004) 1358-1363
13. Stoner E. Three-year safety and efficacy data on the use of Finasteride in the treatment of benign prostatic hyperplasia. Urology 43 (1994) 284-294
14. Talpur N., Echard B., Bagchi D., Bagchi M., and Preuss H.G. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Mol. Cell Biochem. 250 (2003) 21-26
15. Tempany C.M., Parting A.W., Zerhouni E.A., Zinreich S.J., and Walsh P.C. The influence of Finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate 22 (1993) 39-42
16. Valerio L.G., and Gonzales G.F. Toxicological aspects of the South American Herbs Cat's Claw (Uncaria tomentosa) and Maca (Lepidium meyenii). A critical sypnosis. Toxicol. Rev. 24 (2005) 11-35
17. Zeliadt S.B., Etzioni R.D., Penson D.F., Thompson I.M., and Ramsey S.D. Lifetime implications and cost-effectiveness of using Finasteride to prevent prostate cancer. Am. J. Med. 118 (2005) 850-857
18. Zlotta A.R., Teillac P., Raynaud J.P., and Schulman C.C. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride. Eur. Urol. 48 (2005) 269-276